Navigation Links
Global Personalized Medicine Report 2017 - Pharmacogenomics, Pharmacogenetics, Pharmacoproteomics & Metabolomics - Research and Markets
Date:4/6/2017

DUBLIN, Apr. 06, 2017 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Personalized Medicine - Scientific and Commercial Aspects" to their offering.

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics. Basic technologies of molecular diagnostics play an important role, particularly those for single nucleotide polymorphism (SNP) genotyping.

Biomarkers play an important role in personalized medicine. Diagnosis is integrated with therapy for selection of treatment as well for monitoring the results. There is emphasis on early detection and prevention of disease in modern medicine. Biochip/microarray technologies and next generation sequencing are also important. The concept of personalized medicine described in this report remains remains the best way to integrate new technologies such as nanobiotechnology for improving healthcare. Finally bioinformatics is needed to analyze the immense amount of data generated by various technologies.

Various technologies are integrated to develop personalized therapies for specific therapeutic areas described in the report. Examples of this are genotyping for drug resistance in HIV infection, personalized therapy of cancer, antipsychotics for schizophrenia, antidepressant therapy, antihypertensive therapy and personalized approach to neurological disorders. Although genotyping is not yet a part of clinically accepted routine, it is expected to have this status by the year 2020.

Profiles of 320 companies involved in developing technologies for personalized medicines, along with 584 collaborations are included in the part II of the report. Finally the bibliography contains over 750 selected publications cited in the report.The report is supplemented by 80 tables and 38 figures.

Key Topics Covered:

0. Executive Summary

1. Basic Aspects

2. Molecular Diagnostics in Personalized Medicine

3. Pharmacogenetics

4. Pharmacogenomics

5. Role of Pharmacoproteomics

6. Role of Metabolomics in Personalized Medicine

7. Personalized Biological Therapies

8. Personalized Non-pharmacological Therapies

9. Personalized Medicine in Major Therapeutic Areas

10. Personalized Therapy of Cancer

11. Development of Personalized Medicine

12. Ethical, Legal and Regulatory Aspects of Personalized Medicine.

13. Commercial Aspects of Personalized Medicine 

14.  Companies Involved in Developing Personalized Medicine

For more information about this report visit http://www.researchandmarkets.com/research/9qvdct/personalized

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-personalized-medicine-report-2017---pharmacogenomics-pharmacogenetics-pharmacoproteomics--metabolomics---research-and-markets-300436122.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2018)... , ... September 23, 2018 ... ... is widespread in California according to a study published in the prestigious ... Fever Borrelia in California: A Pilot Serological Study” was written by microbiologist ...
(Date:9/15/2018)... ... 2018 , ... EnviroLeather™ by LDI, a leader in PVC-free ... the Carto.graph collection is a graphic expression of mapping the San Francisco Bay ... interior designer, Aileen Avila-Banaag to design the Carto.graph Collection. “I was working on ...
(Date:9/15/2018)... ... September 14, 2018 , ... Harris Teeter announced today ... by Hurricane Florence. , Throughout the month of September, the company invites their ... round up their transaction to the nearest dollar to help support the American ...
Breaking Medicine Technology:
(Date:9/23/2018)... ... September 23, 2018 , ... ... working with healthcare, small business and non-profit organizations, announced today their selection ... Incentive Payment (DSRIP) Technical Assistance (TA) Program and the TA Marketplace ...
(Date:9/22/2018)... TAMPA, Fla. (PRWEB) , ... September 21, 2018 , ... ... LifePath Hospice will open its new inpatient hospice unit on Monday, October 1. The ... Hillsborough County. , “We are excited to partner with an organization like TGH ...
(Date:9/15/2018)... ... September 14, 2018 , ... ... healthcare industry, announced its live training initiative, "ShareNote Live" September, 17-18, 2018 at ... they can maximize its existing features and functionality in the midst of Louisiana’s ...
(Date:9/13/2018)... ... 2018 , ... The Kelly Foundation awarded $83,000 to Saint ... women and children experiencing homelessness in the Sacramento region. The donation will go towards ... doors of Saint John’s open after the County of Sacramento decided not to renew ...
(Date:9/12/2018)... FRAMINGHAM, Mass. (PRWEB) , ... September 12, 2018 , ... ... healthcare provider market, hosted its third annual golf tournament supporting the Dana-Farber Cancer Institute ... an incredible cause,” said John Caccavaro, the tournament director. “I’m happy we have such ...
Breaking Medicine News(10 mins):